News About: Goverment
Number of oriental medicines doctors nearly doubled for 10 years
Korea has seen a dramatic rise in the number of oriental medicines doctors over the last decade, according to a report revealed by the Health Insurance Review and Assessment Service.
The report said that the number...
KPMA seeks to scrap cash incentive policy
Eliminating the illegal rebates from the domestic pharmaceutical industry is part of the drug related reforms on the way to reducing drug prices.
The old system offered no incentives for medical institutions to pur...
Government to slash drug price by 20% in first half
The Ministry of Health and Welfare has recently renewed its strong will to crackdown on unlawful drug marketing activities.
To this end, the ministry said on Wednesday it has a plan to announce a list of drugs to b...
Korea has more hospitals than OCED average
This country has more hospitals than the Organization for Economic Cooperation and Development (OECD) countries on average, but its hospital staff levels are below the normal rate, raising concerns over the quality of...
National Assembly Committee approves medical association’s self-discipline right
The Health and Welfare Committee of the National Assembly Tuesday passed a bill to provide the medical institutions with voluntary discipline rights to efficiently control medical personnel, sending it to a plenary se...
4,180 drugs meet GMP validation standards
The Korea Food and Drug Administration says the new GMP validation system has become firmly established as a result of assessing the validation levels of 244 GMP-endorsed pharmaceutical firms last year.
The KFDA in...
DMF re-notification system to take effect from July 1
The drug master file (DMF) system for re-notification of imported raw materials will be implemented from July 1, the Korea Food and Drug Administration said recently.
Under the current regulation, domestic manufact...
Can Boehringer Ingelheim’s Pradaxa be viable in Korean market?
The Korea Food and Drug Administration (FDA) has recently approved Pradaxa (dabigatran etexilate) capsules to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
As d...
Constipation patients shows 1.5-fold increase in 7 years
The National Health Insurance Corporation (NHIC) said recently that the number of patients being treated for constipation revealed a 1.5-fold rise over the past seven years.
In 2009, 1,427,000 people had their cons...
National Assembly committee approves revisions of pharmaceutical affairs law
Korea's parliamentary committee Friday passed a bill that would, if adopted, make local pharmaceutical industry more competitive as part of efforts to foster the industry as one of the nation’s new growth engines.
...
